Even as the pandemic raged, 31-year-old Meera Yadav, shunned by her family and separated from her eight-year-old child, fought a different battle in 2020. Yadav, a tuberculosis (TB) survivor, filed a public interest litigation in the Bombay High Court, taking the Indian government to task for failing to provide crucial TB drugs to patients. 

In 2018, when Yadav was struggling with end-stage TB, the only thing that helped her was a combination of two drugs, bedaquiline and delamanid. But getting your hands on them is a near-impossible feat; India’s central government tightly controls their distribution. 

AUTHOR

Maitri Porecha

Maitri writes about everything health for The Ken. For close to 10 years now, she has navigated hospital corridors in her search for a good story. In a past life, when she was not a journalist, she used to teach French at her neighbourhood school. Also an avid fan of forensics, she is always up for decoding mysteries in her free time.

View Full Profile

Sign up to our India edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.